A global medical device company launched a study to expand their product’s use for the treatment of OCD.
After a year of recruitment efforts, only 28 participants had been enrolled, far short of the necessary 100 participants.
nRollmed worked closely with site staff to provide qualified pre-screened leads that fit the study’s specifications, including the volume of leads that a site was able to process each month, all within the sponsor’s budget
leads provided by nRollmed
of patients recruited by nRollmed while active
months of recruitment time saved
nRollmed saves medical device company almost a year on OCD trial